skip to Main Content

LED Medical Diagnostics Announces Preliminary Q3 2016 Financial Results

  • October 20, 2016
  • News Releases

Vancouver, British Columbia – October 20, 2016 – LED Medical Diagnostics Inc. (“LED Medical” or the “Company”) is pleased to announce today that preliminary gross revenue numbers for the quarter ending September  30, 2016 are $2.5 million, as measured in US$, representing an approximate 39% increase over the prior year period of $1.8 million. The Company’s revenue for the nine-month period ended September 30, 2016 was $8.3 million, a year-over-year increase of 11% as compared to the $7.5 million result from the same period of 2015. These revenue results are preliminary only and subject to finalization by the Company.

“We move into this year’s period of high sales seasonality with two exciting new products to complement our imaging product portfolio,” stated Lamar Roberts, President of LED Dental. “The TUXEDO intraoral sensor and the RAYSCAN Alpha Plus extraoral imaging system are expected to make positive contributions to company growth going forward.”

For more information, please visit

About LED Medical Diagnostics Inc.

Founded in 2003 and headquartered in Burnaby, British Columbia, Canada, LED Medical Diagnostics Inc., through its wholly-owned subsidiaries LED Dental Inc. and LED Dental Ltd, provide dentists and oral health specialists with advanced diagnostic imaging products and software, in addition to the award-winning VELscope® Vx tissue fluorescence visualization technology. Backed by an experienced leadership team and dedicated to a higher level of service and support, LED Dental is committed to providing dental practitioners with the best technology available by identifying and adding leading products to its growing portfolio.

The Company is currently listed on the TSX Venture Exchange (TSX-V) under the symbol “LMD”, the OTCQX under the symbol “LEDIF”, as well as the Frankfurt Stock Exchange under the symbol “LME”. For more information, call 844.952.7327 or visit